| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.048 | 0.8 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |